What are the consensus estimates for INTERCURE LTD (INCR) next earnings?
The consensus EPS estimate for the next earnings of INTERCURE LTD (INCR) is -0.01 USD and the consensus revenue estimate is 59.16M USD.
INTERCURE LTD (INCR) Forecast, Price Target & Analyst Ratings
NASDAQ:INCR • IL0011063760
Current stock price
0.7601 USD
+0.03 (+4.11%)
At close:
0.773 USD
+0.01 (+1.7%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTERCURE LTD (INCR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q1 / 2024
- EPS Estimate
- -₪0.01
- Revenue Estimate
- 59.16M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.76 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
INCR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about INCR.
In the previous month the buy percentage consensus was at a similar level.
INCR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-04-12 | TD Cowen | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q1 / 2024
- EPS Estimate
- -₪0.01
- Revenue Estimate
- 59.16M
- Revenue Q2Q
- -44.28%
- EPS Q2Q
- -304.00%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 388.684M 76.93% | 355.553M -8.52% | 238.845M -32.82% | 404.94M 69.54% | 574M 41.75% | |
| EBITDA YoY % growth | 75.107M 60.17% | 44.863M -40.27% | -33.919M -175.61% | 47.94M 241.34% | N/A | |
| EBIT YoY % growth | 63.408M 60.53% | 31.697M -50.01% | -49.29M -255.50% | 52.635M 206.79% | 93.503M 77.64% | |
| Operating Margin | 16.31% | 8.91% | -20.64% | 13.00% | 16.29% | |
| EPS YoY % growth | N/A 199.03% | N/A -144.33% | N/A 90.70% | 0.59 1,550.00% | 1.70 187.93% |
All data in ILS
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 -304.00% | -0.02 -119.43% | -0.04 -33.33% | 0.03 106.25% | 0.08 900.00% | 0.12 700.00% | 0.18 550.00% | 0.20 566.67% |
| Revenue Q2Q % growth | 59.16M -44.28% | 69.36M -32.29% | 76.5M -26.17% | 85.68M -75.90% | 92.82M 56.90% | 95.88M 38.24% | 107.1M 40.00% | 109.14M 27.38% |
| EBITDA Q2Q % growth | 8.16M -27.97% | 10.2M -27.77% | 4.08M -48.96% | 6.12M 127.12% | 8.16M | 10.2M | 13.26M 225.00% | 15.3M 150.00% |
| EBIT Q2Q % growth | -1.911M -123.45% | 1.21M -82.59% | 4.38M 51.50% | 9.223M 125.81% | N/A | N/A | N/A | N/A |
All data in ILS
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INTERCURE LTD / INCR Forecast FAQ
How do analysts rate INTERCURE LTD (INCR)?
The consensus rating for INTERCURE LTD (INCR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.